Heartland Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,304
Closed -$714K 116
2021
Q1
$714K Sell
11,304
-3,650
-24% -$227K 0.65% 52
2020
Q4
$928K Buy
+14,954
New +$920K 0.82% 38

Other funds holding BMY

Heartland Bank & Trust's BMY Position: Q2 2021 in Review

Heartland Bank & Trust sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 11,304 shares — an estimated $714K sold.

Heartland Bank & Trust first reported a position in BMY in Q4 2020 and held it in 2 quarters. The position peaked at $928K in Q4 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Heartland Bank & Trust reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Heartland Bank & Trust sold 11,304 Bristol-Myers Squibb shares in Q2 2021, an estimated $714K.
  • Heartland Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 2 quarters.
  • Heartland Bank & Trust's Bristol-Myers Squibb position peaked at $928K in Q4 2020.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Heartland Bank & Trust's 13F filing for Q2 2021, filed 30 Jul 2021.